Pay in 4 interest-free payments of $62.50 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program
(-)-Securinine also induces cell cycle arrest in S phase
8-tetrahydroquinoline
Molecular Weight: 224
their efficacy drop off significantly at the lower 10 mg/kg dose
CV-6209 roxypyridine-2-carboxylate Initial testing of the CENP-ECV 6209 is a potent antagonist of the platelet activating factor (PAF) receptor, with IC50 values of 75 and 170 nM, respectively. CV 6209 has little action on platelet aggregation induced by arachidonic acid, ADP, or collagen. CV 6209 is used to study the role of PAF receptor signaling in vitro and in vivo. Product information CAS Number: 100488 87 7 Molecular Weight: 642. 31 Formula: C34H60ClN3O6 Synonym: [2 methoxy 3 (octadecylcarbamoyloxy)propyl] N
US$ 135.00
US$ 2152.00
US$ 937.00
US$ 2009.50
US$ 135.00
US$ 4101.00